<unk>  is one-year<unk>  after<unk> ation of the lungs. Factors used to predict it include FVC, ventilator use, age, creatinine, NYHA class and diagnosis. It is used for calculation of<unk>  benefit by subtracting another variable called waitlist urgency<unk>  from it. The final lung allocation score, which is meant to reflect the overall<unk>  benefit, incorporates this element as well.
Post-transplant survival measure
History of Modern Biomedicine Research Group
Research into centenarians
Response evaluation criteria in solid tumors
Toxicity category rating
International healthcare accreditation
Monitoring in clinical trials
Phases of clinical research